Oxford Instruments PLC Engages in Share Buyback Program
Oxford Instruments PLC, a leading UK-based company specializing in advanced instrumentation equipment, has been actively participating in a share buyback program. The company, listed on the London Stock Exchange, announced several transactions in its own shares as part of this initiative, which was first announced on June 25, 2025.
On July 14, 2025, Oxford Instruments purchased 20,000 of its own ordinary shares at an average price of 1994.7781 pence per share. The shares were bought through Numis Securities Limited, with prices ranging from 1984.00 to 2005.00 pence. Following this transaction, the total number of ordinary shares in issue was adjusted to 58,026,142.
The following day, on July 15, the company acquired an additional 15,000 shares at an average price of 2015.7950 pence per share. The purchase prices varied between 2010.00 and 2020.00 pence. This transaction reduced the total number of shares in issue to 58,011,142.
On July 16, Oxford Instruments continued its buyback program by purchasing 14,904 shares at an average price of 2023.0183 pence per share. The transaction prices ranged from 2010.00 to 2035.00 pence. After this purchase, the total number of shares in issue stood at 58,086,517.
Throughout these transactions, Oxford Instruments has maintained that it holds no shares in treasury, ensuring that the total number of voting rights remains equal to the number of shares in issue. This information is crucial for shareholders who need to determine if they must notify the company of any changes in their interest.
As of July 14, 2025, the close price of Oxford Instruments’ shares was 2065 pence, with a 52-week high of 2580 pence on July 31, 2024, and a low of 1470 pence on April 6, 2025. The company’s market capitalization stands at 1.17 billion GBP, with a price-to-earnings ratio of 45.38.
Oxford Instruments PLC continues to focus on its core operations in scientific research, chemical analysis, patient monitoring, semiconductor processing, and diagnostic imaging, serving markets in both the UK and the US. For more information, shareholders and interested parties can visit the company’s official website at www.oxford-instruments.com .